DRUG ELUTING STENTS MARKET ANALYSIS

Drug Eluting Stents Market, by Drug (Sirolimus, Paclitaxel, Zotarolimus, Everolimus, Biolimus, and Others), by Coating Type (Polymer-based Coatings and Polymer-free Coatings), by Application (Coronary Artery Disease and Peripheral Artery Disease), by End User (Cardiology Centers, Ambulatory Surgery Centers (ASCs), and Hospitals), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Oct 2022
Code : CMI566
Pages :150
Formats :
Excel and PDF
Industry : Medical Devices

Market News

Global Drug Eluting Stents Market: Key Developments

In February 2020, BIOTRONIK, a medical device company, obtained CE Mark certification for Orsiro mission, a drug eluting stent. The stent shows next-level deliverability for acute performance. The stent is used for improving coronary luminal diameter in patients with coronary artery disease. Safety, efficacy, and clinical performance of Orsiro stent have been investigated in clinical studies with more than 48,500 patients enrolled.